A Howell, D M Barnes, R N Harland, J Redford, V H Bramwell, M J Wilkinson, R Swindell, D Crowther, R A Sellwood. Lancet 1984
Times Cited: 168
Times Cited: 168
Times Cited
Times Co-cited
Similarity
Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.
G M Clark, G W Sledge, C K Osborne, W L McGuire. J Clin Oncol 1987
G M Clark, G W Sledge, C K Osborne, W L McGuire. J Clin Oncol 1987
30
Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.
W A Knight, R B Livingston, E J Gregory, W L McGuire. Cancer Res 1977
W A Knight, R B Livingston, E J Gregory, W L McGuire. Cancer Res 1977
24
Prognostic value of estrogen receptors in primary breast cancer.
R Hähnel, T Woodings, A B Vivian. Cancer 1979
R Hähnel, T Woodings, A B Vivian. Cancer 1979
23
The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.
J M Howat, M Harris, R Swindell, D M Barnes. Br J Cancer 1985
J M Howat, M Harris, R Swindell, D M Barnes. Br J Cancer 1985
21
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
D J Slamon, G M Clark, S G Wong, W J Levin, A Ullrich, W L McGuire. Science 1987
D J Slamon, G M Clark, S G Wong, W J Levin, A Ullrich, W L McGuire. Science 1987
17
Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer.
J F Stewart, R J King, S A Sexton, R R Millis, R D Rubens, J L Hayward. Eur J Cancer 1981
J F Stewart, R J King, S A Sexton, R R Millis, R D Rubens, J L Hayward. Eur J Cancer 1981
17
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.
M R Williams, J H Todd, I O Ellis, C S Dowle, J L Haybittle, C W Elston, R I Nicholson, K Griffiths, R W Blamey. Br J Cancer 1987
M R Williams, J H Todd, I O Ellis, C S Dowle, J L Haybittle, C W Elston, R I Nicholson, K Griffiths, R W Blamey. Br J Cancer 1987
16
The value of estrogen and progesterone receptors in the treatment of breast cancer.
C K Osborne, M G Yochmowitz, W A Knight, W L McGuire. Cancer 1980
C K Osborne, M G Yochmowitz, W A Knight, W L McGuire. Cancer 1980
13
Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
A Alanko, E Heinonen, T Scheinin, E M Tolppanen, R Vihko. Cancer 1985
A Alanko, E Heinonen, T Scheinin, E M Tolppanen, R Vihko. Cancer 1985
13
Progesterone and estrogen receptors as prognostic variables in breast cancer.
B H Mason, I M Holdaway, P R Mullins, L H Yee, R G Kay. Cancer Res 1983
B H Mason, I M Holdaway, P R Mullins, L H Yee, R G Kay. Cancer Res 1983
13
Influence and significance of certain prognostic factors on survival in breast cancer.
A H Paterson, V P Zuck, O Szafran, A W Lees, J Hanson. Eur J Cancer Clin Oncol 1982
A H Paterson, V P Zuck, O Szafran, A W Lees, J Hanson. Eur J Cancer Clin Oncol 1982
23
Survival patterns in hormone treated advanced breast cancer.
M R Williams, J H Todd, R I Nicholson, C W Elston, R W Blamey, K Griffiths. Br J Surg 1986
M R Williams, J H Todd, R I Nicholson, C W Elston, R W Blamey, K Griffiths. Br J Surg 1986
38
Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.
J L Hayward, P P Carbone, J C Heuson, S Kumaoka, A Segaloff, R D Rubens. Cancer 1977
J L Hayward, P P Carbone, J C Heuson, S Kumaoka, A Segaloff, R D Rubens. Cancer 1977
12
Estrogen receptor: a prognostic factor in breast cancer.
N A Samaan, A U Buzdar, K A Aldinger, P N Schultz, K P Yang, M M Romsdahl, R Martin. Cancer 1981
N A Samaan, A U Buzdar, K A Aldinger, P N Schultz, K P Yang, M M Romsdahl, R Martin. Cancer 1981
12
Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up.
J M Raemaekers, L V Beex, A J Koenders, G F Pieters, A G Smals, T J Benraad, P W Kloppenborg. Breast Cancer Res Treat 1985
J M Raemaekers, L V Beex, A J Koenders, G F Pieters, A G Smals, T J Benraad, P W Kloppenborg. Breast Cancer Res Treat 1985
15
Prognostic significance of oestrogen and progestogen receptor activities in breast cancer.
R A Hawkins, G White, N J Bundred, J M Dixon, W R Miller, H J Stewart, A P Forrest. Br J Surg 1987
R A Hawkins, G White, N J Bundred, J M Dixon, W R Miller, H J Stewart, A P Forrest. Br J Surg 1987
22
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.
H J BLOOM, W W RICHARDSON. Br J Cancer 1957
H J BLOOM, W W RICHARDSON. Br J Cancer 1957
10
Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading.
G Blanco, K Holli, M Heikkinen, O P Kallioniemi, P Taskinen. Br J Cancer 1990
G Blanco, K Holli, M Heikkinen, O P Kallioniemi, P Taskinen. Br J Cancer 1990
15
Survival with breast cancer: the importance of estrogen receptor quantity.
L L Shek, W Godolphin. Eur J Cancer Clin Oncol 1989
L L Shek, W Godolphin. Eur J Cancer Clin Oncol 1989
17
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
C W Elston, I O Ellis. Histopathology 1991
C W Elston, I O Ellis. Histopathology 1991
9
Oestrogen receptors and survival in early breast cancer.
R Croton, T Cooke, S Holt, W D George, R Nicolson, K Griffiths. Br Med J (Clin Res Ed) 1981
R Croton, T Cooke, S Holt, W D George, R Nicolson, K Griffiths. Br Med J (Clin Res Ed) 1981
15
Relation between estrogen receptor concentration and clinical and histological factors: their relative prognostic importance after radical mastectomy for primary breast cancer.
G Andry, S Suciu, D Pratola, R Sylvester, G Leclercq, P M da Costa, N Legros, M Andry-t'Hooft, A Verhest, W Mattheiem. Eur J Cancer Clin Oncol 1989
G Andry, S Suciu, D Pratola, R Sylvester, G Leclercq, P M da Costa, N Legros, M Andry-t'Hooft, A Verhest, W Mattheiem. Eur J Cancer Clin Oncol 1989
25
Estrogen receptors and long-term prognosis in breast cancer.
S Aamdal, O Børmer, O Jørgensen, H Høst, G Eliassen, O Kaalhus, A Pihl. Cancer 1984
S Aamdal, O Børmer, O Jørgensen, H Høst, G Eliassen, O Kaalhus, A Pihl. Cancer 1984
11
Association between steroid hormone receptor status and disease-free interval in breast cancer.
J C Allegra, M E Lippman, R Simon, E B Thompson, A Barlock, L Green, K K Huff, H M Do, S C Aitken, R Warren. Cancer Treat Rep 1979
J C Allegra, M E Lippman, R Simon, E B Thompson, A Barlock, L Green, K K Huff, H M Do, S C Aitken, R Warren. Cancer Treat Rep 1979
9
Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients.
A Insa, A Lluch, F Prosper, I Marugan, A Martinez-Agullo, J Garcia-Conde. Breast Cancer Res Treat 1999
A Insa, A Lluch, F Prosper, I Marugan, A Martinez-Agullo, J Garcia-Conde. Breast Cancer Res Treat 1999
9
Progesterone receptors as a prognostic factor in Stage II breast cancer.
G M Clark, W L McGuire, C A Hubay, O H Pearson, J S Marshall. N Engl J Med 1983
G M Clark, W L McGuire, C A Hubay, O H Pearson, J S Marshall. N Engl J Med 1983
9
Oestrogen receptors and prognosis in early breast cancer.
T Cooke, D George, R Shields, P Maynard, K Griffiths. Lancet 1979
T Cooke, D George, R Shields, P Maynard, K Griffiths. Lancet 1979
8
Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.
J R Sainsbury, J R Farndon, G K Needham, A J Malcolm, A L Harris. Lancet 1987
J R Sainsbury, J R Farndon, G K Needham, A J Malcolm, A L Harris. Lancet 1987
8
Multivariate analysis of prognostic factors in metastatic breast cancer.
G N Hortobagyi, T L Smith, S S Legha, K D Swenerton, E A Gehan, H Y Yap, A U Buzdar, G R Blumenschein. J Clin Oncol 1983
G N Hortobagyi, T L Smith, S S Legha, K D Swenerton, E A Gehan, H Y Yap, A U Buzdar, G R Blumenschein. J Clin Oncol 1983
8
Survival after first recurrence of breast cancer. The Miami experience.
C L Vogel, S Azevedo, S Hilsenbeck, D R East, J Ayub. Cancer 1992
C L Vogel, S Azevedo, S Hilsenbeck, D R East, J Ayub. Cancer 1992
12
The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients.
L Vollenweider-Zerargui, L Barrelet, Y Wong, T Lemarchand-Béraud, F Gómez. Cancer 1986
L Vollenweider-Zerargui, L Barrelet, Y Wong, T Lemarchand-Béraud, F Gómez. Cancer 1986
8
The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.
J M Howat, D M Barnes, M Harris, R Swindell. Br J Cancer 1983
J M Howat, D M Barnes, M Harris, R Swindell. Br J Cancer 1983
12
Prognostic value of estrogen and progesterone receptors in primary breast cancer.
S Saez, F Cheix, B Asselain. Breast Cancer Res Treat 1983
S Saez, F Cheix, B Asselain. Breast Cancer Res Treat 1983
10
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
Dalia M Abd El-Rehim, Graham Ball, Sarah E Pinder, Emad Rakha, Claire Paish, John F R Robertson, Douglas Macmillan, Roger W Blamey, Ian O Ellis. Int J Cancer 2005
Dalia M Abd El-Rehim, Graham Ball, Sarah E Pinder, Emad Rakha, Claire Paish, John F R Robertson, Douglas Macmillan, Roger W Blamey, Ian O Ellis. Int J Cancer 2005
8
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
C Wright, B Angus, S Nicholson, J R Sainsbury, J Cairns, W J Gullick, P Kelly, A L Harris, C H Horne. Cancer Res 1989
C Wright, B Angus, S Nicholson, J R Sainsbury, J Cairns, W J Gullick, P Kelly, A L Harris, C H Horne. Cancer Res 1989
7
Human breast cancer: survival from first metastasis. Breast Cancer Study Group.
P G Koenders, L V Beex, P W Kloppenborg, A G Smals, T J Benraad. Breast Cancer Res Treat 1992
P G Koenders, L V Beex, P W Kloppenborg, A G Smals, T J Benraad. Breast Cancer Res Treat 1992
12
23
Oestrogen-receptor status and sites of metastasis in breast cancer.
F C Campbell, R W Blamey, C W Elston, R I Nicholson, K Griffiths, J L Haybittle. Br J Cancer 1981
F C Campbell, R W Blamey, C W Elston, R I Nicholson, K Griffiths, J L Haybittle. Br J Cancer 1981
9
Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.
G M Clark, C K Osborne, W L McGuire. J Clin Oncol 1984
G M Clark, C K Osborne, W L McGuire. J Clin Oncol 1984
7
Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
S M Thorpe, C Rose, B B Rasmussen, H T Mouridsen, T Bayer, N Keiding. Cancer Res 1987
S M Thorpe, C Rose, B B Rasmussen, H T Mouridsen, T Bayer, N Keiding. Cancer Res 1987
7
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.
C L Carter, C Allen, D E Henson. Cancer 1989
C L Carter, C Allen, D E Henson. Cancer 1989
7
Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis.
E F Solomayer, I J Diel, G C Meyberg, C Gollan, G Bastert. Breast Cancer Res Treat 2000
E F Solomayer, I J Diel, G C Meyberg, C Gollan, G Bastert. Breast Cancer Res Treat 2000
7
Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading.
F F Parl, B P Schmidt, W D Dupont, R K Wagner. Cancer 1984
F F Parl, B P Schmidt, W D Dupont, R K Wagner. Cancer 1984
7
Relationship of presence of progesterone receptors to prognosis in early breast cancer.
M F Pichon, C Pallud, M Brunet, E Milgrom. Cancer Res 1980
M F Pichon, C Pallud, M Brunet, E Milgrom. Cancer Res 1980
6
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
M J van de Vijver, J L Peterse, W J Mooi, P Wisman, J Lomans, O Dalesio, R Nusse. N Engl J Med 1988
M J van de Vijver, J L Peterse, W J Mooi, P Wisman, J Lomans, O Dalesio, R Nusse. N Engl J Med 1988
6
The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
J Alexieva-Figusch, W L Van Putten, M A Blankenstein, J Blonk-Van Der Wijst, J G Klijn. Cancer 1988
J Alexieva-Figusch, W L Van Putten, M A Blankenstein, J Blonk-Van Der Wijst, J G Klijn. Cancer 1988
6
Prognostic factors in metastatic breast cancer treated with combination chemotherapy.
K D Swenerton, S S Legha, T Smith, G N Hortobagyi, E A Gehan, H Y Yap, J U Gutterman, G R Blumenschein. Cancer Res 1979
K D Swenerton, S S Legha, T Smith, G N Hortobagyi, E A Gehan, H Y Yap, J U Gutterman, G R Blumenschein. Cancer Res 1979
6
Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence.
C Kamby, B B Rasmussen, B Kristensen. Br J Cancer 1989
C Kamby, B B Rasmussen, B Kristensen. Br J Cancer 1989
7
Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.
A Goldhirsch, R D Gelber, M Castiglione. J Clin Oncol 1988
A Goldhirsch, R D Gelber, M Castiglione. J Clin Oncol 1988
6
Classification of patients with disseminated cancer of the breast.
S J Cutler, J A Ardyce, S G Taylor. Cancer 1969
S J Cutler, J A Ardyce, S G Taylor. Cancer 1969
6
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.